// company-profile
Nurix Therapeutics, Inc. Insider Trading
NRIXEvery SEC Form 4 insider trading filing for Nurix Therapeutics, Inc. (NRIX) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.
curl "https://api.form4api.com/v1/transactions?ticker=NRIX" -H "X-Api-Key: YOUR_API_KEY"// activity-summary
Recent insider activity is bullish. Over the last 30 days, 18 insiders purchased shares versus 3 sales. Buying was led by Hansen Gwenn.
// 90-day insight
Over the last 90 days, Nurix Therapeutics, Inc. insiders bought $0 (23 transactions) and sold $246K (3 transactions).
- Most active insider: Ring Christine with 23 transactions totaling $1.8M.
- Largest single sale: $581K by Ring Christine on Jun 25, 2026.
- 77% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Nurix Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 5, 2026 | Hansen Gwenn | NRIX | Option Exercise10b5 | 4,356 | $1.86 | $8K |
| Aug 5, 2026 | Hansen Gwenn | NRIX | Sale10b5 | 4,356 | $25.00 | $109K |
| Aug 5, 2026 | Hansen Gwenn | NRIX | Option Exercise10b5 | 4,356 | $0.00 | $0K |
| Aug 4, 2026 | Hansen Gwenn | NRIX | Sale10b5 | 2,611 | $24.64 | $64K |
| Aug 4, 2026 | van Houte Hans | NRIX | Sale10b5 | 2,967 | $24.65 | $73K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →